Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer.
JAMA 306(14):1557-65 (2011) PMID 21990299
Attempts to determine the clinical significance of BRCA1/2 mutations in ovarian cancer have produced conflicting results.
DOI: 10.1001/jama.2011.1456
Version: za2963e q8za1 q8zb4 q8zc6 q8zd4 q8ze0 q8zfa q8zgc